2024
|
Invention
|
Tgf-beta receptor type ii fusion proteins and uses thereof.
In certain aspects, the present disc... |
|
Invention
|
Actrii proteins for the treatment of pulmonary arterial hypertension (pah).
In some aspects, the... |
|
Invention
|
Actrii proteins and use in treating post-capillary pulmonary hypertension.
In some aspects, the ... |
|
Invention
|
Actriib binding agents and uses thereof.
The disclosure provides, among other aspects, neutraliz... |
|
Invention
|
Multispecific binders of tgfbeta-superfamily ligands and uses thereof.
In certain aspects, the d... |
|
Invention
|
Alk4:actriib heteromultimers and uses thereof.
In certain aspects, the disclosure provides solub... |
|
Invention
|
Activin type 2 receptor binding proteins and methods of making them.
This disclosure provides Ac... |
|
Invention
|
Alk7 antagonists and uses thereof.
In certain aspects, the disclosure provides ALK7 antagonists.... |
|
Invention
|
Methods for treating myeloproliferative disorders.
In part, the present disclosure relates metho... |
|
Invention
|
Alk7 binding proteins and uses thereof.
This disclosure provides ALK7-binding proteins such as a... |
|
Invention
|
Compositions and methods for treating pulmonary hypertension.
In some aspects, the invention tea... |
|
Invention
|
Method for promoting bone growth using activin-actriia antagonists.
In certain aspects, the pres... |
2023
|
Invention
|
Compositions and methods for treating spinal muscular atrophy.
In certain aspects, the disclosur... |
|
Invention
|
Tgf-beta superfamily type i and type ii receptor heteromultimers and uses thereof.
In certain as... |
|
Invention
|
Treatments for complications associated with chronic liver disease.
In certain aspects, the pres... |
|
Invention
|
Treatments for hermansky-pudlak syndrome.
In certain aspects, the present disclosure relates to ... |
|
Invention
|
Twisted gastrulation polypeptides and uses thereof. In certain aspects, the present invention pro... |
2022
|
Invention
|
Activin-actrii antagonists and uses for treating anemia.
Provided herein are methods for the tre... |
|
Invention
|
Compositions and methods for treating renal diseases or conditions.
In some aspects, the disclos... |
|
Invention
|
Compositions and methods for treating renal diseases or conditions. In some aspects, the disclosu... |
|
Invention
|
Actrii proteins and uses thereof.
In some aspects, the disclosure relates to compositions and me... |
|
Invention
|
Actrii proteins and uses thereof. In some aspects, the disclosure relates to compositions and met... |
|
Invention
|
Compositions and methods for treating pulmonary hypertension.
In some aspects, the disclosure re... |
|
Invention
|
Compositions and methods for treating pulmonary hypertension. In some aspects, the disclosure rel... |
|
Invention
|
Actrii proteins and uses thereof. e.g.e.g.e.g., pulmonary hypertension associated with chronic ob... |
|
Invention
|
Actrii-alk4 antagonists and methods of treating heart failure.
In some aspects, the disclosure r... |
2021
|
Invention
|
Formulations comprising actrii polypeptide variants.
In certain aspects, the present disclosure ... |
|
Invention
|
Single-arm actriia and actriib heteromultimers and methods for treating renal diseases or conditi... |
|
Invention
|
Variant actriib proteins and uses thereof.
In certain aspects, the present invention provides no... |
2020
|
Invention
|
Single-arm actriia and actriib heteromultimers and methods for treating pulmonary hypertension.
... |
|
Invention
|
Treatments for systemic sclerosis.
In certain aspects, the present disclosure relates to methods... |
2019
|
Invention
|
Multispecific binders of tgfbeta-superfamily ligands and uses thereof. In certain aspects, the di... |